AGN-210669 ophthalmic solution

· Allergan

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AGN-210669 ophthalmic solution, covering 2013-10-18 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing